Hjem › Endometriekreft › Arizona › Phoenix
Kliniske studier for Endometriekreft i Phoenix, AZ
12 studier for Endometriekreft søker deltakere på steder i og rundt Phoenix (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekruttererFase 3
- Cancer Center at Saint Joseph's, Phoenix
A Phase 1 Study of the Safety and Tolerability of CTX-10726
RekruttererFase 1
- Mayo Clinic Arizona, Phoenix
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RekruttererObservasjonsstudie
- Mayo Clinic, Phoenix
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RekruttererFase 3
- HonorHealth Research Inst, Phoenix
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RekruttererFase 2
- HonorHealth, Phoenix
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Mayo Clinic, Phoenix
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruttererFase 1/2
- USOR HonorHealth, Phoenix
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Investigative Site #132, Phoenix
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruttererFase 1/2
- Mayo Clinic Comprehensive Cancer Center, Phoenix
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruttererFase 1/2
- Mayo Clinic, Phoenix
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
RekruttererObservasjonsstudie
- Mayo Clinic in Arizona, Phoenix
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
RekruttererFase 2
- Honor Health, Phoenix
Endometriekreft-studier i andre byer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Columbus, OH25 studier
- Oklahoma City, OK25 studier
- Chicago, IL25 studier
Andre studier i Phoenix
- Brystkreft25 studier
- Kolorektal kreft25 studier
- Fedme22 studier
- Metastatisk kreft20 studier
- Ikke-småcellet lungekreft20 studier
- Hjertesvikt18 studier
- Kreft (alle typer)17 studier
- Prostatakreft17 studier
- Kardiovaskulær sykdom16 studier
- Multipelt myelom16 studier
- Pankreaskreft16 studier
- Overvekt15 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.